over MgSO4. Concentrated in vacuo and purified by flash chrom-
atography (7 : 1 hexanes–EtOAc) gave 6 (287 mg, 53%). Mp
139–141 °C. 1H NMR (CDCl3, 400 MHz), δ = 7.53 (s, 1 H), 7.4
(s, 1 H), 4.68 (s, 2 H), 4.36 (s, 2 H), 3.79 (s, 3 H), 2.36 (s, 1 H).
13C NMR (CDCl3, 100 MHz), δ = 155.06, 136.47, 132.11,
132.01, 130.93, 117.38, 62.29, 59.85, 49.02. MS (EI) Calcd for
C9H10BrN3O2 (M + H) 272.10; Found 272.2. Anal. Calcd for
C9H10BrN3O2: C, 39.73; H, 3.70; N, 15.44. Found: C, 39.81; H,
3.74; N, 15.49.
395.25; Found 395.3. Anal. Calcd for C16H19BrN4O3: C, 48.62;
H, 4.85; N, 14.18. Found: C, 48.69; H, 4.82; N, 14.22.
1-(5-Bromo-3-formyl-2-hydroxy-benzyl)-1H-[1,2,3]triazole-
4-carboxylic acid butylamide, 2
BBr3 (10 mmol, 10 mL, 1 M in DCM) was slowly added to a
solution of 3 (1 mmol, 394 mg) in dichloromethane (20 mL) and
the solution was stirred under argon at room temperature. After
4 hours, the mixture was poured slowly into a solution of satu-
rated sodium bicarbonate (100 mL) to obtain a precipitation of a
grey solid. After filtrated and washed with cold water and ether,
the crude product was further purified by column chromato-
graphy (CH2Cl2–MeOH, 4 : 1) to yield 2 (304 mg, 80%) as an
1-(5-Bromo-3-hydroxymethyl-2-methoxy-benzyl)-1H-[1,2,3]-
triazole-4-carboxylic acid methyl ester, 5
A solution of 6 (1 mmol, 127 mg), propynoic acid methyl ester
(2.2 mmol, 222 mg), sodium ascorbate (0.2 mmol, 44.6 mg),
and CuSO4 (0.02 mmol, 5.6 mg) in a 1 : 1 mixture of EtOH–
H2O (14 mL) was stirred at room temperature for 24 h. After
removal of the solvents in vacuo, the crude product was purified
by column chromatography (CH2Cl2–MeOH, 3 : 1) to afford 5
1
off-white solid. Mp 175–177 °C. H NMR (CDCl3, 400 MHz),
δ = 11.44 (s, 1 H), 9.87 (s, 1 H), 8.16 (s, 1 H), 7.73 (s, 1 H),
7.63 (s, 1 H), 7.11 (s, 1 H), 5.59 (s, 2 H), 3.44 (m, 2 H), 1.60
(m, 2 H), 1.40 (m, 2 H), 0.94 (t, 3 H, J = 7.2 Hz). 13C NMR
(CDCl3, 100 MHz), δ = 195.27, 159.77, 158.04, 143.65, 139.74,
136.54, 125.80, 125.06, 121.76, 111.59, 47.57, 38.77, 31.54,
19.95, 13.63. MS (EI) Calcd for C15H17BrN4O3 (M + H)
381.22; Found 381.3. Anal. Calcd for C15H17BrN4O3: C, 47.26;
H, 4.49; N, 14.70. Found: C, 47.34; H, 4.53; N, 14.64.
1
(309 mg, 94%). Mp 191–193 °C. H NMR (CDCl3, 400 MHz),
δ = 8.10 (s, 1 H), 7.65 (s, 1 H), 7.29 (s, 1 H), 5.56 (s, 2 H), 4.75
(s, 2 H), 3.92 (s, 3 H), 3.76(s, 3 H), 2.75 (s, 1 H). 13C NMR
(CDCl3, 100 MHz), δ = 160.92, 154.88, 140.11, 137.18, 133.21,
132.00, 128.94, 127.64, 117.68, 62.27, 59.40, 52.18, 48.71. MS
(EI) Calcd for C13H14BrN3O4 (M + H) 356.17; Found 356.2.
Anal. Calcd for C13H14BrN3O4: C, 43.84; H, 3.96; N, 11.80.
Found: C, 43.88; H, 3.99; N, 11.74.
1-[5-Bromo-3-(2,2-dicyano-vinyl)-2-hydroxy-benzyl]-1H-[1,2,3]-
triazole-4-carboxylic acid butylamide, 1
Piperidine (0.025 mmol, 25 μL) was added to a mixture of 2
(0.5 mmol, 190 mg) and malononitrile (0.5 mmol, 33 mg) in
ethanol (20 mL). The solution was stirred at room temperature
overnight and the resulting precipitate was collected by filtration.
The crude product was purified by column chromatography
(CH2Cl2–MeOH, 5 : 1) to yield compound 1 (169 mg, 79%) as a
1-(5-Bromo-3-hydroxymethyl-2-methoxy-benzyl)-1H-[1,2,3]-
triazole-4-carboxylic acid butylamide, 4
5 (1 mmol, 127 mg) in 4 mL butylamine was stirred at 70 °C for
4 h. After removal of butylamine in vacuo, the crude product
was purified by column chromatography (CH2Cl2–MeOH, 3 : 1)
1
1
to afford 4 (309 mg, 94%). Mp 187–189 °C. H NMR (CDCl3,
pale white solid. Mp 203–205 °C. H NMR (CDCl3, 400 MHz),
400 MHz), δ = 8.05 (s, 1 H), 7.63 (s, 1 H), 7.27 (s, 1 H), 7.16
(s, 1 H), 5.52 (s, 2 H), 4.72 (s, 2 H), 3.75 (s, 3 H), 3.42 (q, 2 H,
J = 7.2 Hz), 2.54 (s, 1 H), 1.58 (m, 2 H), 1.39 (m, 2 H), 0.93 (t,
3 H, J = 7.2 Hz), 13C NMR (CDCl3, 100 MHz), δ = 159.90,
154.93, 143.67, 137.15, 133.19, 132.07, 129.18, 125.41, 117.74,
62.30, 59.52, 48.69, 38.88, 31.58, 20.03, 13.70. MS (EI) Calcd
for C16H21BrN4O3 (M + H) 397.27; Found 397.3. Anal. Calcd
for C16H21BrN4O3: C, 48.37; H, 5.33; N, 14.10. Found: C,
48.41; H, 5.37; N, 14.06.
δ = 8.22 (s, 1 H), 8.18 (s, 1 H), 7.76 (s, 1 H), 7.62 (s, 1 H), 7.12
(s, 1 H), 5.79 (s, 2 H), 3.44 (d, 2 H, J = 8 Hz), 1.56 (t, 2 H, J =
4 Hz), 1.40 (m, 2H), 0.94 (t, 3 H, J = 8 Hz). 13C NMR (CDCl3,
100 MHz), δ = 162.87, 162.40, 139.83, 136.07, 133.78, 133.60,
133.53, 129.48, 129.15, 124.80, 123.50, 122.92, 40.97, 30.27,
20.35, 13.91, 1.156. MS (EI) Calcd for C18H17BrN6O2 (M + H)
429.27; Found: 429.3. Anal. Calcd for C18H17BrN6O2: C, 50.36;
H, 3.99; N, 19.58. Found: C, 50.46; H, 3.95; N, 19.49.
Acknowledgements
1-(5-Bromo-3-formyl-2-methoxy-benzyl)-1H-[1,2,3]triazole-4-
carboxylic acid butylamide, 3
This work was supported by the National Nature Science Foun-
dation of China (21031006), NSFC-DFG joint fund (TRR 61)
and the National Basic Research 973 Program of China.
Pyridinium chlorochromate (1.5 mmol, 322 mg) was added to a
solution of 4 (1 mmol, 396 mg) in CH2Cl2 under a nitrogen
atmosphere, and the mixture was stirred at room temperature
overnight. The crude product was purified by column chromato-
graphy (CH2Cl2) to afford 3 (355 mg, 90%). Mp 178–180 °C.
1H NMR (CDCl3, 400 MHz), δ = 10.26 (s, 1 H), 8.11 (s, 1 H),
7.97 (d, 1 H, J = 2.4 Hz), 7.60 (d, 1 H, J = 2.0 Hz), 7.12 (s, 1
H), 5.60 (s, 1 H), 3.92 (s, 1 H), 3.44 (q, 2 H, J = 6.8 Hz), 1.59
(m, 2 H), 1.41 (m, 2 H), 0.94 (t, 3 H, J = 7.2 Hz). 13C NMR
(CDCl3, 100 MHz), δ = 187.30, 159.80, 159.64, 143.91, 138.51,
133.40, 130.84, 130.77, 125.54, 118.11, 65.32, 47.95, 38.83,
31.55, 19.99, 13.66. MS (EI) Calcd for C16H19BrN4O3 (M + H)
Notes and references
1 R. Dutzler, E. B. Campbell, M. Cadene, B. T. Chait and R. MacKinnon,
Nature, 2002, 415, 287–294.
2 C. R. Wade, A. E. J. Broomsgrove, S. Aldridge and F. P. Gabbai, Chem.
Rev., 2010, 110, 3958–3984.
3 M. Cametti and K. Rissanen, Chem. Commun., 2009 (20), 2809–2829.
4 R. J. Brea, C. Reiriz and J. R. Granja, Chem. Soc. Rev., 2010, 39, 1448–
1456; S. E. Matthews and P. D. Beer, Supramol. Chem., 2005, 17, 411–
435; R. Martínez-Máñez and F. Sancenón, Chem. Rev., 2003, 103, 4419–
4476; P. D. Beer and P. A. Gale, Angew. Chem., Int. Ed., 2001, 40, 486–
This journal is © The Royal Society of Chemistry 2012
Org. Biomol. Chem., 2012, 10, 4375–4380 | 4379